To examine the identification of biosignatures related to cognitive symptoms that may indicate a neurodevelopmental risk for schizophrenia.
Commentary on the findings presented by Koutsouleris et al. regarding biosignatures and cognitive symptoms.
Discussion of the implications for understanding schizophrenia and its early indicators.
Cognitive basic symptoms serve as potential biosignatures for a distinct neurodevelopmental pathway to schizophrenia.
Abstract
This scientific commentary refers to ‘Biosignatures of cognitive basic symptoms mark a distinct neurodevelopmental pathway to schizophrenia’ by Koutsouleris et al. (https://doi.org/10.1093/brain/awag100).